International Journal of Radiation Oncology * Biology * Physics
Volume 81, Issue 2 , Pages 369-375 , 1 October 2011

The Use of the Active Breathing Coordinator Throughout Radical Non–Small-Cell Lung Cancer (NSCLC) Radiotherapy

Received 25 July 2009 ,Revised 18 May 2010 ,Accepted 24 May 2010.

References 

  1. Kupelian PA, Komaki R, Allen P. Prognostic factors in the treatment of node-negative non small cell lung carcinoma with radiotherapy alone. Int J Radiat Oncol Biol Phys. 1996;36:607–613
  2. Rengan R, Rosenzweig KE, Venkatraman E, et al. Improved local control with higher doses of radiation in large-volume stage III non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2004;60:741–747
  3. Saunders M, Dische S, Barrett A, et al. Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: A randomised multicentre trial. CHART Steering Committee. Lancet. 1997;350:161–165
  4. Graham MV, Purdy JA, Emami B, et al. Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys. 1999;45:323–329
  5. Kwa SL, Lebesque JV, Theuws JC, et al. Radiation pneumonitis as a function of mean lung dose: An analysis of pooled data of 540 patients. Int J Radiat Oncol Biol Phys. 1998;42:1–9
  6. Chemotherapy in non-small cell lung cancer. A meta-analysis using updated data on individual patients from 52 randomised clinical trials. Non-small Cell Lung Cancer Collaborative Group. BMJ. 1995;311:899–909
  7. Furuse K, Fukuoka M, Kawahara M, et al. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer. J Clin Oncol. 1999;17:2692–2699
  8. Gordon GS, Vokes EE. Chemoradiation for locally advanced, unresectable NSCLC. New standard of care, emerging strategies. Oncology (Williston Park). 1999;13:1075–1088discussion 1088, 1091–1094
  9. Rowell NP, O'Rourke NP. Concurrent chemoradiotherapy in non-small cell lung cancer. Cochrane Database Syst Rev. 2004;(4):CD002140
  10. Socinski MA, Zhang C, Herndon JE, et al. Combined modality trials of the Cancer and Leukemia Group B in stage III non-small-cell lung cancer: Analysis of factors influencing survival and toxicity. Ann Oncol. 2004;15:1033–1041
  11. Zatloukal P, Petruzelka L, Zemanova M, et al. Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized study. Lung Cancer. 2004;46:87–98
  12. Chavaudra J, Bridier A. [Definition of volumes in external radiotherapy: ICRU reports 50 and 62]. Cancer Radiother. 2001;5:472–478
  13. George R, Chung TD, Vedam SS, et al. Audio-visual biofeedback for respiratory-gated radiotherapy: Impact of audio instruction and audio-visual biofeedback on respiratory-gated radiotherapy. Int J Radiat Oncol Biol Phys. 2006;65:924–933
  14. Shirato H, Shimizu S, Kunieda T, et al. Physical aspects of a real-time tumor-tracking system for gated radiotherapy. Int J Radiat Oncol Biol Phys. 2000;48:1187–1195
  15. Zhang T, Keller H, O'Brien MJ, et al. Application of the spirometer in respiratory gated radiotherapy. Med Phys. 2003;30:3165–7311
  16. Nuyttens JJ, Prevost JB, Praag J, et al. Lung tumor tracking during stereotactic radiotherapy treatment with the CyberKnife: Marker placement and early results. Acta Oncol. 2006;45:961–965
  17. Negoro Y, Nagata Y, Aoki T, et al. The effectiveness of an immobilization device in conformal radiotherapy for lung tumor: Reduction of respiratory tumor movement and evaluation of the daily setup accuracy. Int J Radiat Oncol Biol Phys. 2001;50:889–898
  18. Denissova SI, Yewondwossen MH, Andrew JW, et al. A gated deep inspiration breath-hold radiation therapy technique using a linear position transducer. J Appl Clin Med Phys. 2005;6:61–70
  19. Kim DJ, Murray BR, Halperin R, et al. Held-breath self-gating technique for radiotherapy of non-small-cell lung cancer: A feasibility study. Int J Radiat Oncol Biol Phys. 2001;49:43–49
  20. Mah D, Hanley J, Rosenzweig KE, et al. Technical aspects of the deep inspiration breath-hold technique in the treatment of thoracic cancer. Int J Radiat Oncol Biol Phys. 2000;48:1175–1185
  21. Nelson C, Starkschall G, Balter P, et al. Respiration-correlated treatment delivery using feedback-guided breath hold: a technical study. Med Phys. 2005;32:175–181
  22. Onishi H, Kuriyama K, Komiyama T, et al. CT evaluation of patient deep inspiration self-breath-holding: How precisely can patients reproduce the tumor position in the absence of respiratory monitoring devices?. Med Phys. 2003;30:1183–1187
  23. Wilson EM, Williams FJ, Lyn BE, et al. Validation of active breathing control in patients with non-small-cell lung cancer to be treated with CHARTWEL. Int J Radiat Oncol Biol Phys. 2003;57:864–874
  24. Wong JW, Sharpe MB, Jaffray DA, et al. The use of active breathing control (ABC) to reduce margin for breathing motion. Int J Radiat Oncol Biol Phys. 1999;44:911–919
  25. Panakis N, McNair HA, Christian JA, et al. Defining the margins in the radical radiotherapy of non-small cell lung cancer (NSCLC) with active breathing control (ABC) and the effect on physical lung parameters. Radiother Oncol. 2008;87:65–73
  26. van Herk M. Errors and margins in radiotherapy. Semin Radiat Oncol. 2004;14:52–64
  27. McNair HA, Brock J, Symonds-Tayler JR, et al. Feasibility of the use of the Active Breathing Co ordinator (ABC) in patients receiving radical radiotherapy for non-small cell lung cancer (NSCLC). Radiother Oncol. 2009;93:424–429
  28. Koshani R, Balter JM, Hayman JA, et al. Short-term and long-term reproducibility of lung tumor position using active breathing control (ABC). Int J Radiat Oncol Biol Phys. 2006;65:1553–1559
  29. Fox J, Ford E, Redmond K, et al. Quantification of tumor volume changes during radiotherapy for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2009;74:341–348
  30. Senan S, van Sornsen de Koste J, Samson M, et al. Evaluation of a target contouring protocol for 3D conformal radiotherapy in non-small cell lung cancer. Radiother Oncol. 1999;53:247–255
  31. Burnett SS, Sixel KE, Cheung PC, et al. A study of tumor motion management in the conformal radiotherapy of lung cancer. Radiother Oncol. 2008;86:77–85
  32. Partridge M, Tree A, Brock J, et al. Improvement in tumour control probability with active breathing control and dose escalation: a modelling study. Radiother Oncol. 2009;91:325–329

 This work was undertaken in The Royal Marsden NHS Foundation Trust, which received a proportion of its funding from the NHS Executive; the views expressed in this publication are those of the authors and not necessarily those of the NHS Executive. This work was supported by the Institute of Cancer Research, The Royal Marsden NHS Foundation Trust, and Cancer Research UK Section of Radiotherapy [CRUK] grant number C46/A2131. We acknowledge NHS funding to the NIHR Biomedical Research Center.

 Conflict of interest: none.

PII: S0360-3016(10)00761-3

doi: 10.1016/j.ijrobp.2010.05.038

International Journal of Radiation Oncology * Biology * Physics
Volume 81, Issue 2 , Pages 369-375 , 1 October 2011

Article Tools

* Image Usage & Resolution